This week, we will discuss two trials with a joint IPNA JC session. PREDNOS 2 explores and explodes the steroids use in URTI to prevent relapse practice, while another noninferiority trial reports use of lower dose steroids in managing relapses.
Summary of the CAPTIVATE platform which will be a twitter spaces discussion
This week, we will discuss a registry trial: can a nationwide nudge fix a CKD treatment gap?
This week, we will discuss a pediatric nephrology trial: is tacrolimus superior to MMF in FRNS and SDNS?
This week, we will discuss a NEJM trial on uncontrolled hypertension: lorundrostat, an aldosterone synthase inhibitor, aims at the hormonal dark side driving resistance.